Target intelligence / Profile preview

TATA-box binding protein associated factor 9 (TAF9)

Target
TAF9
Molecular classification
Transcription factor subunit, General transcription factor complex component, Chromatin-associated protein
01

Overview

TATA-box binding protein associated factor 9 (TAF9) is a highly conserved subunit of the transcription factor IID (TFIID) complex, which is crucial for the initiation of transcription by RNA polymerase II. TFIID consists of the TATA-binding protein (TBP) and multiple TBP-associated factors (TAFs), including TAF9. TAF9 acts as a coactivator in transcriptional regulation, participating in both activation and repression of gene transcription, in part through direct interactions with transcriptional activators such as p53 and VP16, as well as several other TAFs and general transcription factors. TAF9 is essential for cell viability and gene expression, forming part of several chromatin-associated complexes involved in promoter recognition and pre-initiation complex assembly. Its ability to stabilize and regulate p53 links it to apoptosis and potential roles in cancer biology. No approved therapeutic drugs specifically target TAF9; direct targeting would likely pose significant safety concerns due to its central role in general transcription[1][2][3][4].

Other names
TAF9TAF2GTAFII31TAFII-31TAFII-32TAFII32TAFIID32MGC5067CGI-137MGC1603MGC3647AD-004RNA polymerase II TBP-associated factor subunit GSTAF31/32Transcription initiation factor TFIID 31 kDa subunitTranscription initiation factor TFIID 32 kDa subunit
02

Biological functions

Transcription initiation by RNA polymerase IIPromoter recognition (core promoter binding)Coactivator activityRepression of gene expressionRegulation of apoptosis (cell death)Protein–protein interaction with general transcription factors and transcriptional activators (e.g., p53)Cell viability regulation
03

Disease associations

Cancer (by interaction/stabilization of p53)Neurodegenerative disease (Spinocerebellar ataxia 7)Viral infection (Herpes simplex)Other (potential role in apoptosis and cell survival)
04

Safety considerations

Essential for cell viability; global inhibition is likely incompatible with lifeTargeting may disrupt general transcription, leading to toxicityPotential for promoting or inhibiting apoptosis depending on context

Beyond the preview

Go deeper on TATA-box binding protein associated factor 9 (TAF9).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TATA-box binding protein associated factor 9 (TAF9).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call